Reig Jofre reduces its profits by 17% during the first quarter of 2026

The pharmaceutical company Reig Jofre reduced its profit by 17% in the first quarter of 2026 compared to the same period last year, to 3.1 million euros, as reported by the company to the National Securities Market Commission (CNMV).